ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: McDonnell Foundation Awards Four Fellowships; UCLA’s Kenneth Shine Is Next IOM President

January 10, 1992

NCI To Seek Proposals For Less Invasive Detection, Diagnosis, Treatment Technologies

July 3, 1998

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

Alternative to Animal Use In Research Outlined By OTA

February 21, 1986

DCCPT Board, NCAB Approve Core Grant Guideline Changes, Consortium Centers

May 17, 1985